Literature DB >> 12891602

Clinical outcomes following stent implantation in internal mammary artery grafts.

Arvind K Sharma1, Scott McGlynn, Sue Apple, Ellen Pinnow, Daniel A Canos, Natalie Gevorkian, Mihaela Tebeica, Luis Gruberg, Augusto D Pichard, Joseph Lindsay.   

Abstract

We evaluated our experience with percutaneous coronary intervention (PCI) of internal mammary artery (IMA) grafts. From the institution's database we identified 288 patients with 311 IMA lesions. Of these, 82 (26.4%) had stents placed during PCI. Angiographic success was 92%. Mortality at 1 month was 1.7%, myocardial infarction (MI) 15.7%, and target lesion revascularization (TLR) 0.4%. Cumulative 1-year event rates were mortality 6.4%, MI 20.4%, and TLR 8.0%. TLR rates were significantly higher in the stented lesions than lesions treated with angioplasty alone (19.2% vs. 4.9%; P = 0.004). The higher TLR rate in stented lesions was most apparent at the anastomotic site (25.0% vs. 4.2%; P = 0.006). Percutaneous revascularization of IMA grafts can be performed safely with high procedural success and excellent short- and long-term results. Stenting, particularly at the anastomotic site, was associated with significantly greater rates of TLR than angioplasty alone. Copyright 2003 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2003        PMID: 12891602     DOI: 10.1002/ccd.10580

Source DB:  PubMed          Journal:  Catheter Cardiovasc Interv        ISSN: 1522-1946            Impact factor:   2.692


  3 in total

Review 1.  Secondary revascularization after CABG surgery.

Authors:  Javier Escaned
Journal:  Nat Rev Cardiol       Date:  2012-07-10       Impact factor: 32.419

2.  Percutaneous coronary intervention for distal coronary graft anastomosis le-sions: a case series.

Authors:  A Tassopoulos; M Didagelos; I Tsiafoutis; A Ziakas; M Koutouzis
Journal:  Hippokratia       Date:  2019 Apr-Jun       Impact factor: 0.471

Review 3.  Contemporary coronary artery bypass graft surgery and subsequent percutaneous revascularization.

Authors:  Frans J Beerkens; Bimmer E Claessen; Marielle Mahan; Mario F L Gaudino; Derrick Y Tam; José P S Henriques; Roxana Mehran; George D Dangas
Journal:  Nat Rev Cardiol       Date:  2021-10-05       Impact factor: 32.419

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.